We look forward to showcasing our innovative approach targeting difficult to treat cancers at the 2023 Bits & Pretzels Healthtech event in Munich 20-21 June.
One-carbon therapeutics AB management at ESMO to discuss the ODIN clinical phase 1/2 trial with potential clinical sites across Europe
One-carbon therapeutics AB is discussing the ODIN trial with several
